FDA Commissioner Marty Makary Resigns Amid Industry Backlash The sudden resignation of Food and Drug Administration (FDA) Commissioner Marty Makary has sent shockwaves through the healthcare industry, sparking questions about the implications for US healthcare policy and regulatory frameworks.
As details surrounding his departure unfold, one thing is clear: his tenure was marked by controversy and backlash from industry stakeholders.
Background: A Look at Marty Makary's Tenure as FDA Commissioner Makary was appointed as FDA Commissioner in 2022, bringing a reputation for being a pro business regulator.